“We are encouraged by CMS’s proposed decision to provide Medicare coverage for uRDN in patients with uncontrolled hypertension—a population that continues to face significant unmet need,” said Lara Barghout, CEO of Recor Medical.
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
“We are encouraged by CMS’s proposed decision to provide Medicare coverage for uRDN in patients with uncontrolled hypertension—a population that continues to face significant unmet need,” said Lara Barghout, CEO of Recor Medical.